Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Innate immunity in the liver.

Zhiping Li1, Anna Mae Diehl

  • 1Department of Medicine, The Johns Hopkins University, Baltimore, Maryland 21205, USA.

Current Opinion in Gastroenterology
|February 11, 2005
PubMed
Summary

Defects in the liver's innate immune system, particularly natural killer T cells, can drive inflammation and insulin resistance in conditions like nonalcoholic steatohepatitis. Therapies targeting this inflammation may offer benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same author

Disrupted Mitochondrial Copper Homeostasis Promotes Ferroptotic Stress, Senescence and MASLD Progression.

bioRxiv : the preprint server for biology·2026
Same author

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

Nature communications·2026
Same author

A unimolecular GLP-1 and FGF21 dual agonist for treatment of metabolic dysfunction-associated steatohepatitis.

Communications medicine·2026
Same author

Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.

Hepatology (Baltimore, Md.)·2026
Same author

Hepatocyte hedgehog signaling controls ferroptosis to alleviate aging-related organ dysfunction.

JCI insight·2026

Area of Science:

  • Immunology
  • Hepatology
  • Innate Immunity

Background:

  • The liver acts as a crucial immune organ, constantly exposed to gastrointestinal-derived antigens.
  • Innate immune cells like Kupffer cells, natural killer (NK) cells, and natural killer T (NKT) cells are abundant in the liver.
  • The innate immune system plays a significant role in chronic liver diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

Purpose of the Study:

  • To review recent advancements in understanding the regulatory mechanisms of the hepatic innate immune system.
  • To explore the role of the innate immune system in the pathogenesis of chronic liver diseases, specifically NAFLD and NASH.

Main Methods:

  • Review of current literature on hepatic innate immunity.
  • Focus on the function and regulation of hepatic natural killer T cells.
  • Examination of animal models (ob/ob mice) for NAFLD and NASH.

Main Results:

  • Hepatic NKT cells balance pro-inflammatory (Th-1) and anti-inflammatory (Th-2) cytokines, modulating liver injury.
  • NKT cell depletion promotes Th-1 polarization, increasing hepatotoxicity.
  • Dysregulation of NKT cells, influenced by Kupffer cells and norepinephrine, contributes to inflammation and insulin resistance in NAFLD/NASH models.

Conclusions:

  • Defects in hepatic innate immunity, leading to Th-1 polarization, are implicated in the pathology of hepatic insulin resistance and NASH.
  • Therapeutic strategies aimed at inhibiting inflammatory activity may prove beneficial for treating these liver disorders.

Related Experiment Videos